Goiter epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Akshun Kalia (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{ARK}} | {{CMG}}; {{AE}} {{ARK}} | ||
==Overview== | ==Overview== | ||
The [[incidence]] of goiter is approximately 1400 to 1700 per 100,000 individuals in females and 900 per 100,000 individuals in males, worldwide. The [[prevalence]] of goiter is approximately 3000 per 100,000 individuals worldwide, for single thyroid nodules. The frequency of goiter increases in women over 45 years of age. The rate of occurrence of goiter in females is higher than | The [[incidence]] of goiter is approximately 1400 to 1700 per 100,000 individuals in females and 900 per 100,000 individuals in males, worldwide. The [[prevalence]] of goiter is approximately 3000 per 100,000 individuals worldwide, for single [[Thyroid nodule|thyroid nodules]]. The [[frequency]] of goiter increases in women over 45 years of age. The rate of occurrence of goiter in females is higher than in males by a ratio of 4:1. There is no racial predilection to goiter. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
| Line 12: | Line 12: | ||
===Prevalence=== | ===Prevalence=== | ||
*The [[prevalence]] of goiter is approximately 3000 for single thyroid nodules per 100,000 individuals worldwide.<ref name="pmid21893493">{{cite journal |vauthors=Vanderpump MP |title=The epidemiology of thyroid disease |journal=Br. Med. Bull. |volume=99 |issue= |pages=39–51 |year=2011 |pmid=21893493 |doi=10.1093/bmb/ldr030 |url=}}</ref><ref name="Vanderpump2011">{{cite journal|last1=Vanderpump|first1=M. P. J.|title=The epidemiology of thyroid disease|journal=British Medical Bulletin|volume=99|issue=1|year=2011|pages=39–51|issn=0007-1420|doi=10.1093/bmb/ldr030}}</ref><ref name="pmid19460960">{{cite journal| author=Zimmermann MB| title=Iodine deficiency. | journal=Endocr Rev | year= 2009 | volume= 30 | issue= 4 | pages= 376-408 | pmid=19460960 | doi=10.1210/er.2009-0011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19460960 }} </ref> | *The [[prevalence]] of goiter is approximately 3000 for single [[Thyroid nodule|thyroid nodules]] per 100,000 individuals worldwide.<ref name="pmid21893493">{{cite journal |vauthors=Vanderpump MP |title=The epidemiology of thyroid disease |journal=Br. Med. Bull. |volume=99 |issue= |pages=39–51 |year=2011 |pmid=21893493 |doi=10.1093/bmb/ldr030 |url=}}</ref><ref name="Vanderpump2011">{{cite journal|last1=Vanderpump|first1=M. P. J.|title=The epidemiology of thyroid disease|journal=British Medical Bulletin|volume=99|issue=1|year=2011|pages=39–51|issn=0007-1420|doi=10.1093/bmb/ldr030}}</ref><ref name="pmid19460960">{{cite journal| author=Zimmermann MB| title=Iodine deficiency. | journal=Endocr Rev | year= 2009 | volume= 30 | issue= 4 | pages= 376-408 | pmid=19460960 | doi=10.1210/er.2009-0011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19460960 }} </ref> | ||
===Age=== | ===Age=== | ||
*The frequency of goiter increases in women over 45 years of age.<ref name="pmid21893493">{{cite journal |vauthors=Vanderpump MP |title=The epidemiology of thyroid disease |journal=Br. Med. Bull. |volume=99 |issue= |pages=39–51 |year=2011 |pmid=21893493 |doi=10.1093/bmb/ldr030 |url=}}</ref><ref name="pmid7641412">{{cite journal |vauthors=Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F |title=The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey |journal=Clin. Endocrinol. (Oxf) |volume=43 |issue=1 |pages=55–68 |year=1995 |pmid=7641412 |doi= |url=}}</ref> | *The [[Frequency dependent selection|frequency]] of goiter increases in women over 45 years of age.<ref name="pmid21893493">{{cite journal |vauthors=Vanderpump MP |title=The epidemiology of thyroid disease |journal=Br. Med. Bull. |volume=99 |issue= |pages=39–51 |year=2011 |pmid=21893493 |doi=10.1093/bmb/ldr030 |url=}}</ref><ref name="pmid7641412">{{cite journal |vauthors=Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F |title=The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey |journal=Clin. Endocrinol. (Oxf) |volume=43 |issue=1 |pages=55–68 |year=1995 |pmid=7641412 |doi= |url=}}</ref> | ||
===Sex=== | ===Sex=== | ||
Revision as of 15:44, 13 October 2017
|
Goiter Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Goiter epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Goiter epidemiology and demographics |
|
Risk calculators and risk factors for Goiter epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
The incidence of goiter is approximately 1400 to 1700 per 100,000 individuals in females and 900 per 100,000 individuals in males, worldwide. The prevalence of goiter is approximately 3000 per 100,000 individuals worldwide, for single thyroid nodules. The frequency of goiter increases in women over 45 years of age. The rate of occurrence of goiter in females is higher than in males by a ratio of 4:1. There is no racial predilection to goiter.
Epidemiology and Demographics
Incidence
- The incidence of goiter is approximately 1400 to 1700 per 100,000 individuals in females and 900 per 100,000 individuals in males, worldwide.[1][2][3]
Prevalence
- The prevalence of goiter is approximately 3000 for single thyroid nodules per 100,000 individuals worldwide.[4][5][6]
Age
Sex
- The rate of occurrence of goiter in females is higher than that in males by a ratio of 4:1.[8]
Race
- There is no racial predilection to goiter.
References
- ↑ VANDER JB, GASTON EA, DAWBER TR (1954). "Significance of solitary nontoxic thyroid nodules; preliminary report". N Engl J Med. 251 (24): 970–3. doi:10.1056/NEJM195412092512403. PMID 13214371.
- ↑ Freire-Maia, Ademar; Freire-Maia, Dértia Villalba; Morton, Newton E. (1982). "Epidemiology and Genetics of Endemic Goiter". Human Heredity. 32 (3): 176–180. doi:10.1159/000153286. ISSN 1423-0062.
- ↑ Freire-Maia DV, Freire-Maia A, Schull WJ, Morton NE, Quelce-Salgado A, Lobo LC (1983). "Epidemiology and genetics of endemic goiter. I. Epidemiological aspects". Isr. J. Med. Sci. 19 (1): 11–6. PMID 6832943.
- ↑ 4.0 4.1 Vanderpump MP (2011). "The epidemiology of thyroid disease". Br. Med. Bull. 99: 39–51. doi:10.1093/bmb/ldr030. PMID 21893493.
- ↑ Vanderpump, M. P. J. (2011). "The epidemiology of thyroid disease". British Medical Bulletin. 99 (1): 39–51. doi:10.1093/bmb/ldr030. ISSN 0007-1420.
- ↑ Zimmermann MB (2009). "Iodine deficiency". Endocr Rev. 30 (4): 376–408. doi:10.1210/er.2009-0011. PMID 19460960.
- ↑ Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F (1995). "The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey". Clin. Endocrinol. (Oxf). 43 (1): 55–68. PMID 7641412.
- ↑ Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA (1977). "The spectrum of thyroid disease in a community: the Whickham survey". Clin. Endocrinol. (Oxf). 7 (6): 481–93. PMID 598014.